Meloxicam

Meloxicam, meloxicam, 71125-38-7, Mobic, Metacam, Mobicox, Movalis, Movatec, Mobec, Coxicam, Meloxivet, Melfax, UH-AC 62XX, Meloxicamum, Meloxidolor, Meloxoral, Rheumocam, Vivlodex, Melosus, RevitaCAM, Acticam, Contacera, Emdocam, Flexicam, Inflacam, Loxicom, Melovem, Meloxidyl, Recocam, UHAC-62XX, DTXSID1020803, VG2QF83CGL, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, UH-AC-62 XX, ANJESO, CHEBI:6741, QMIIZ ODT, N-1539, DTXCID70803, miloxicam, N1539, ZELERIS COMPONENT MELOXICAM, SYMBRAVO COMPONENT MELOXICAM, ZYNRELEF COMPONENT MELOXICAM, 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methylthiazolyl)-, 1,1-dioxide, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide, Masflex, Movicox, Alloxate, Ostilox, Meloxicam Injection, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1$l^(6),2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1$l^{6},2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1$l^(6),2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1$l^{6},2-benzothiazine-3-carboxamide, Metacam Oral Suspension, RefChem:5991, OroCAM Transmucosal Oral Spray, Meloxicam Solution for Injection, M01AC06, Metacam 5 mg/mL Solution for Injection, 2H-1,2-Benzothiazine-3-carboximidic acid, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1lambda6,2-benzothiazine-3-carboxamide, 615-253-8, Meloxicam (Mobic), Parocin, Meloxicamum [Latin], 4-Hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide, Tenaron, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, C14H13N3O4S2, UNII-VG2QF83CGL, 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide, MFCD00868752, CHEMBL599, MLS000028587, s1734, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide, NCGC00018248-04, SMR000058994, Revmoksikam, Coxflam, Melonex, CAS-71125-38-7, CCRIS 9139, Movalis, , Meloxicam CRS, Recoxa, , HSDB 7741, Melox, , Mobic, , Meloxicam [USAN:USP:INN:BAN], QAMZOVA, XIFYRM, Meloxicam (Standard), Mobic (TN), Opera_ID_2, Spectrum_001633, MELOXICAM [INN], MELOXICAM [JAN], MELOXICAM [MI], MELOXICAM [HSDB], MELOXICAM [USAN], Spectrum2_000941, Spectrum3_000649, Spectrum4_000787, Spectrum5_001813, MELOXICAM [VANDF], Meloxicam impurity standard, Epitope ID:613442, MELOXICAM [MART.], MELOXICAM [USP-RS], MELOXICAM [WHO-DD], SCHEMBL3576, Meloxicam (JAN/USP/INN), Lopac0_000766, SCHEMBL33369, BSPBio_002257, KBioGR_001234, KBioSS_002113, MLS001304725, MLS001306413, MLS006011422, BIDD:GT0726, SCHEMBL713100, SPECTRUM1504150, Meloxicam - Bio-X trade mark, SPBio_000902, MELOXICAM [GREEN BOOK], GTPL7220, orb1310257, orb3139837, MELOXICAM [ORANGE BOOK], CHEMBL1741042, MELOXICAM [EP MONOGRAPH], SCHEMBL23589638, HY-B0261R, KBio2_002113, KBio2_004681, KBio2_007249, KBio3_001477, ETI-511, MELOXICAM [USP MONOGRAPH], MSK7155, GLXC-07998, HMS1922D19, HMS2089B18, HMS2096I19, HMS2234P07, HMS2236C09, HMS3259H06, HMS3372C13, HMS3372P18, HMS3655K06, HMS3713I19, HMS3744K09, HMS3884G08, HMS5079D20, ALBB-027268, HY-B0261, Tox21_111734, Tox21_113192, Tox21_201689, Tox21_302756, BBL029076, BDBM50056998, CCG-39098, EBC-12958, HSCI1_000045, MSK7155-100A, STK620505, AKOS000279442, AKOS026749959, Tox21_111734_1, AC-1325, DB00814, FH25045, KS-1084, MELOXICAM [EMA EPAR VETERINARY], NC00698, SMP2_000133, Meloxicam 100 microg/mL in Acetonitrile, NCGC00018248-01, NCGC00018248-02, NCGC00018248-03, NCGC00018248-05, NCGC00018248-06, NCGC00018248-07, NCGC00018248-08, NCGC00018248-10, NCGC00018248-23, NCGC00018248-24, NCGC00018248-25, NCGC00018248-26, NCGC00022924-03, NCGC00022924-04, NCGC00256316-01, NCGC00259238-01, NCGC00263878-02, (3E)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1|E6,2-benzothiazine-3-carboxamide, BH164661, SMR000718800, Meloxicam 1000 microg/mL in Acetonitrile, DB-055490, Meloxicam 1.0 mg/ml in Dimethyl Sulfoxide, M1959, NS00000018, SW219562-1, EN300-52507, Meloxicam Solution in Acetonitrile, 100ug/mL, C08169, D00969, F20356, M02128, AB00383033-17, AB00383033-18, AB00383033_20, AN-668/13244001, Q414028, SR-01000003132-10, F2173-0387, Z1695493323, Meloxicam Working Standard (Secondary Reference Standard), 4-hydroxy-2-methyl-N-(5-methy-2-thiazolyl)-2H-1,2-benzothiazine-3-caboxamide-1,1-dioxide, 3-{hydroxy[(5-methyl-1,3-thiazol-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione, 4-Hydroxy-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e][1,2]thiazine-3-carboxylic acid (5-methyl-thiazol-2-yl)-amide, 4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e][1,2]thiazine-3-carboxylic acid (5-methyl-thiazol-2-yl)-amide, 4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1,2-dihydro-1lambda~6~,2-benzothiazine-3-carboxamide, 4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda{6},2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazole)-2H-1,2-benzothiazine-3 -carboxamide 1,1-dioxide, 4-hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide, 4-Hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide1,1-dioxide